Skip to main content

Sethu Sankaranarayanan, PhD

Vice President, Preclinical and Translational Sciences at Nine Square Therapeutics

Location: San Francisco, CA United States

Sethu Sankaranarayanan is an accomplished scientist with broad experience in drug discovery and neurodegenerative disease. He obtained a PhD in neuroscience from Washington State University and pursued postdoctoral research experiences at the Max-Planck Institute in Heidelberg and the Weill Medical College of Cornell University. Dr. Sankaranarayanan heads the translational biomarkers group at Nine Square. He previously held scientific leadership roles at early-stage biotech and pharmaceutical companies, including Escape Bio, Annexon, Bristol-Myers Squibb and Merck. During his tenure at these organizations, Dr. Sankaranarayanan led the discovery and development of both small molecule and antibody-based therapies and biomarkers for diverse areas such as neurodegeneration, ophthalmology and autoimmune disease. He has contributed significantly to the successful progression of several molecules from early discovery to clinical studies.

Associated Grants

  • Development of Parkin Activators for the Treatment of Parkinson’s Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.